MedTrace Logo

Unbound Bilirubin Levels in Healthy Term and Late Preterm Infants

NCT03237715 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2017-08-02

No results posted yet for this study

Summary

Specific Aim 1: To determine total serum bilirubin (TSB) and unbound bilirubin (Bf) levels in term and late preterm infants during the first week of life.

Specific Aim 2: Measure Bf levels in breast fed and formula fed infants and examine their relationship to unbound fatty acid (FFAu) levels.

Specific Aim 3: To demonstrate that phototherapy results in different changes in TSB and Bf.

Conditions

  • Neonatal Jaundice

Interventions

OTHER

Assessment of unbound bilirubin levels

Collection of residual blood for measurement of unbound bilirubin

Sponsors & Collaborators

  • Rutgers University

    lead OTHER

Eligibility

Min Age
6 Hours
Max Age
7 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03237715 on ClinicalTrials.gov